Psilocybin trials for Major Depressive Disorder

All Psilocybin trials · All Major Depressive Disorder trials

Phase breakdown

Recruiting trials studying Psilocybin for Major Depressive Disorder

• A Randomized Neuroimaging Trial of Psilocybin in Depression
  NCT06072898 · Phase: Phase 2 · Ages: 18 Years to 64 Years · Sex: All (male and female) · 1 location
• Effect of Psilocybin and Structured Integrated Reframing Therapy on Gut-Brain Axis Biomarkers and Depression in Major Depressive Disorder
  NCT07703722 · Phase: Phase 3 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 3 locations
• Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder
  NCT06592833 · Phase: Phase 2 · Ages: 21 Years to 80 Years · Sex: All (male and female) · 1 location
• Psilocybin rTMS for Treatment Resistant Depression
  NCT06132178 · Phase: Phase 2 · Ages: 22 Years to 65 Years · Sex: All (male and female) · 1 location
• The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder
  NCT06247839 · Phase: Phase 3 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Psilocybin for Major Depressive Disorder?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.